Paid Clinical Trials in Cheyenne, WY
As of August 2026, 33 paid clinical trials are recruiting in Cheyenne, Wyoming. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Cheyenne offers studies at sites including Memorial Hospital of Laramie County for conditions such as Dermatitis Atopic, Malignant Solid Neoplasm, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Cheyenne
Trials by drug in Cheyenne
Filter results
Newly added in Cheyenne
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Virtual Nurse and Social Worker Palliative Care Team to Improve Quality of Life in Veterans With Heart Failure or COPD
30 clinical trials
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Family Communications After Genetic Testing
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Molecular Genetics Studies of Cancer Patients and Their Relatives
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Top Research Study Locations in Cheyenne
Researchers run research studies in Cheyenne, WY at 11 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Memorial Hospital of Laramie County | Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 22 |
| Cheyenne Regional Medical Center-West | Acral Lentiginous Melanoma, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | 3 |
| Cheyenne Eye Clinic & Surgery Center | Glaucoma, Open-Angle, Ocular Hypertension | 1 |
| Cheyenne Skin Clinic | Dermatitis Atopic | 1 |
| Cheyenne VA Medical, Cheyenne, WY | Heart Failure, Interstitial Lung Disease, Pulmonary Disease, Chronic Obstructive | 1 |
| Decentralized / At-Home Participation (U.S.) | Healthy Adult Participants | 1 |
| Home-based telemedicine | Chronic Granulomatous Disease (CGD) | 1 |
| Ohio State University Telemedicine | Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer AJCC v8 | 1 |
| UCHealth Cheyenne Medical Specialists | Obesity | 1 |
| UCHealth Primary Care - Cheyenne | Obesity | 1 |
| Wyoming Research Foundation | Dermatitis Atopic | 1 |
Active & Upcoming Studies in Cheyenne (2026)
Recruiting trials in Cheyenne grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (20 active studies)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
- Family Communications After Genetic Testing · Alliance for Clinical Trials in Oncology
Cardiovascular (2 active studies)
- Virtual Nurse and Social Worker Palliative Care Team to Improve Quality of Life in Veterans With Heart Failure or COPD · VA Office of Research and Development
- Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes. · Phase 3 · Amneal Pharmaceuticals, LLC
Diabetes & metabolic (1 active study)
- PATHWEIGH: Pragmatic Weight Management in Primary Care · University of Colorado, Denver
Eye & vision (1 active study)
Common conditions studied in Cheyenne
- Dermatitis Atopic (2 active studies)
- Malignant Solid Neoplasm (2 active studies)
- Stage III Pancreatic Cancer AJCC v8 (2 active studies)
- Stage IV Pancreatic Cancer AJCC v8 (2 active studies)
- Acral Lentiginous Melanoma (1 active study)
- Acute Lymphoblastic Leukemia (1 active study)
Leading research sponsors in Cheyenne
- Alliance for Clinical Trials in Oncology
- ECOG-ACRIN Cancer Research Group
- SWOG Cancer Research Network
- NRG Oncology
- Sanofi
Frequently asked questions
How many paid clinical trials are currently recruiting in Cheyenne?
There are approximately 33 recruiting clinical trials in Cheyenne, Wyoming listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Cheyenne pay participants?
Most recruiting trials in Cheyenne compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Cheyenne?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Cheyenne?
The most common conditions under active study in Cheyenne include Dermatitis Atopic (2), Malignant Solid Neoplasm (2), Stage III Pancreatic Cancer AJCC v8 (2), Stage IV Pancreatic Cancer AJCC v8 (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Cheyenne?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Cheyenne on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Cheyenne?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Cheyenne?
Recruiting research sites in Cheyenne include Memorial Hospital of Laramie County, Cheyenne Regional Medical Center-West, Cheyenne Eye Clinic & Surgery Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Cheyenne right now?
The largest active categories in Cheyenne are Cancer & tumors (20), Cardiovascular (2), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.